Objective: to analyze population-based incidence, anatomicd istributiona nd patient characteristics of gastrointestinal carcinoid tumours.
INtroDUCtIoN
Carcinoids area mong the most common tumours arising from neuroendocrine cells. these tumours have been demonstrated in most parts of the body, but aremost commonly found in the gastrointestinal tract and lungs. the tumoursh ave diverse pathologic findings that typically correspond to the site of origin (1). thet erm "carcinoid"h as recentlyb een criticized as outdated and the new World Health organization classification recommendt hat the term "carcinoid" should be synonymous with well-differentiated neuroendocrine tumour and "malignantcarcinoid" being an alternative to the term well-differentiated endocrine carcinoma (2). the true incidence for carcinoid tumoursi sd isputed andr ates varyingb etween 0,4 and 4.5 per 100.000 per year arep ublished (3-6). American data suggest that the incidencei si ncreasing (5), and it should be noted that necropsy studies have shown incidencerates as high as 1% (7), although this high incidence might be ar esult of selection bias in personsrecruited to autopsy. As for the site of occurrence it is assumed that this correlates with the density of neuroendocrine cells at that location. Appendix, small intestine, and rectum account for moret han 90% of carcinoids occurring in the gastrointestinal tract with tumoursm ost frequentlyf ound in the ileum. However,anatomic distribution of primary tumours within the gastrointestinal tract varies considerably in published studies (3-6).
the purpose of this study was to analyze incidence data of carcinoids in Western Norway.F urther,w e wanted to studydistributionofcarcinoids in the gastrointestinal tract and relate this to survival rates.
PAtIENtS AND MEtHoDS
By searching the database of the Gade Institute of pathology,Haukeland University Hospital for the period 1983 to 2003 we found 88 patients with carcinoid tumours. this number was used to calculate the incidence of carcinoids. the Gade Institute of Pathology serves the counties Hordaland and Sogn og Fjordane in Western Norway with a population of 550.000. to avoid selection bias in patients referred to the department of Surgery,Haukeland University Hospital, incidence was also calculated based on the population of 350.000 served by this department. the university hospitalisalso the major local hospital in its catchment area with an annual frequency of 350 appendectomies. All appendices from this hospital areassumed to be sent to pathology.Fifty-one patientswith carcinoid tumours -26(52%) males and 25 (48%) females -weretreated at the department of surgery,H aukeland University Hospital. these patients form the basis for analysis of tumour location, treatment and prognosis. Variables analysed were: primary tumour location, number of tumours, presenting symptoms, sex, and age, location of metastases, treatment, recurrence and survival.
Statistical analysis was performed using SPSS 11 for Windows.r elevant variables werea nalyzed by contingency tables and Chi-squares tatistics, and p-values<0 ,05 were assumed statistically significant.
rESUltS
By analyzing data files from the department of pathology we found 88 carcinoids per 550.000i nhabitants in 20 years, which gives an incidence of 0.8 per 100.000. When incidence was analyzed with data from the departmentofsurgery we found 51 patients per 340.000 in 20 years which also gives an incidence of 0.8 per 100.000. of 51 patients treated at the department of surgery, Haukeland University Hospital therew ere2 6m en and 25 women with amedian age at diagnosis of 61 years (range 17-87 years). location of primary carcinoid tumours is shown in table 1. Mostofthe carcinoid tumours found in patients younger than 40 years werelocated in the appendix, and patientswith tumours at this location had a median age of 33 years. Some patientsh ad moret han one tumour,a nd totally we found 63 tumoursin51patients. In two patients we also found additional cancers (adenocarcinomas in the stomach). Most carcinoid tumours located within the gastrointestinal tract occurred in the small bowel (53%) and appendix (18%). Small bowel carcinoid tumours weredistributed predominately in the ileum (61%) and less frequently in the jejunum (25%). the most common symptom in patients with carcinoids was abdominalpain. Symptoms versus location areg iven in table 2. Carcinoid syndromeo ccurred in five patients (2 men and 3women) and the median ageo ft his group was 68 years (31 to 79 years). Primaryt umours in these patients werea ll located in the ileum. Four of the five patients had documented liverm etastases. the most frequent symptoms in patients who developedcarcinoid syndrome wered iarrhea (80%), flushing (80%), weight loss (40%) and dyspnoea (40%).
Multiple carcinoids werefound in 10 out of 51 patients. Amongthe patients with carcinoids at two different sites, one had tumours located in the esophagus and ileum, three had tumours in the ileum and colon and one patient had carcinoidsinjejunum and ileum. 50% of ileal carcinoids weremultifocal.
At surgery we found metastases in 31 (61%) patients.None of thecarcinoid tumoursinthe appendix or rectum had metastasized. In contrast,four of five 49 patients (96%) had their tumour resected and of these1 9u nderwent emergency surgery.t he main indication for emergencys urgery was abdominal pain. Following surgical treatment, 27 patients (55%) had ac urative resection. Palliation was achievedi n 11 patients( 22%), and seven tumours (14%) were found to be irresectable. Among the 19 patients who underwent emergency surgery,10(53%) experienced completerelief of symptoms, fourpatients(21%) had partial alleviation and two had no improvement of their symptoms.
twelve patients with metastatic disease received adjuvant non-surgical treatment, and of these four had carcinoid syndrome. Seven patients (14%) were treated using embolization of metastatic tumoursi n the liver.
Following surgery,eight patients (16%) had recurrence of carcinoid tumours, and most common recurrence was found in the liver.r ecurrence was most often found in patients with ap rimary tumour located in the ileum.
overall median survival for all patients was 14 years, with a5-year survival of 59%. 5-year survival was 40% in patients with tumours in the small bowel, 100% in appendiceal tumours and rectum and 50% for patients with carcinoids in the colon (Fig. 1) . In univariate analysesw ef ound that younger patients had better survival, but this effect disappeared when controlled for tumour location.Inpatients with metastatic disease the overall 5-years survival rate was 41%.
DISCUSSIoN
The main finding in this paper was an incidence of neuroendocrine carcinoids of 0.8 per 100.000. Most tumours werel ocated in the small bowel, and most patients wered iagnosed following gastrointestinal symptoms. Curative treatmentw as obtained in 55% of the patientsw ith an overall 5-year survival of 59%.
As for the incidence of carcinoids this is in keeping with results from other Scandinavian studies (4, 6), whereas others have found amuch higher frequency (5, 7). one of the reasons for this variation might be implementation of screening programs, as al arge number of carcinoid tumours areasymptomatic.
In contrast to other series we did not find any gender predominance with regards to incidence. this is in contrast to what was found in the Danish and Swedish series (4, 6) which both discovered an in- creased risk in women compared to men. the American SEErstudy also revealed aslight preponderance of carcinoids in women (5). the median age at the time of surgery was 61 years. This corresponds to findingsinother studies(5, 6, 8).
In accordance with other studies we also found that patients with carcinoid tumours in the appendix were the youngest( median age 33 years),a nd those with small bowel carcinoids werethe oldest (5).
reported anatomic distribution of primary tumours shows great variation depending on the source of data analysed. According to older published series carcinoids aremost commonly found in appendix (9), whereas morer ecent data from the American SEEr population have shown that small bowel is the most commonsite of carcinoids (5). In our series most carcinoid tumours occurred in the small bowel (53%), followed by appendix( 18%), colon and rectum (4% each), stomach (8%) and duodenum (10%). the reason fort his variation in distributiono fc arcinoids might be institutional biasesd ue to screening programmesand varying frequencies of appendectomies performed at specific hospitals. Carcinoids in appendix might also be treated on alower level of carethan moreadvanced carcinoid tumours.
It is generally assumed that carcinoid tumours in the appendixr arely metastasize. the reason for this might be that appendiceal tumours arediagnosed in an early stage and often also incidentally.Incontrast to carcinoids in the appendix, most carcinoids in the ileum weres ymptomatic at the timeo fd iagnosis, they werem ost commonly associated with metastases, and ag reat number developed carcinoid syndrome. Ac lassic carcinoid syndrome was found in 10% in this study and this is about the same magnitude as found in other series (10) . Carcinoids yndrome was most common found in patients with primary ileal tumours.
We found that multiple carcinoids occurred mainly in ileum. other series have found multifocal carcinoids in 12%-46% with the highest frequency in the foregut (3, 10). It is also well known that non-carcinoid malignancies occur frequently in patients with gastrointestinal carcinoid tumours.W ef ound that two out of our 51 patients had another primarymalignancy,w hereas other studies haver eported an even higher incidence (5, 11).
Carcinoid tumours may behave as incidental benign lesions or as highly metastatic tumours. the occurrence of metastases from carcinoid tumours is directly related to the size of the primary tumour and to the location of the tumour.Ifthe primary tumour is localized and resectable 5-years urvival rates are excellent. Even in patients with distant metastasis, survival is rather favorable with amedian survival of 5y ears (10) . In our series we found a5 9% overall cancer-specific 5-year survival. This is in agreement with other studies (3, 5, 8). We found no difference in survivalf or men andw omen,w hich is in keeping with some studies (8), whereas others have found better survival for women than for men (12, 13) . Similar to other studies(8) our results suggested that midgut carcinoids and especially carcinoids in the ileum, tendedt ob em ost aggressive and carry ap oorer prognosis than foregut and hindgut carcinoids.However,i ts hould be taken into account that ileal carcinoids have ag reater tendency to metastasize than tumoursfromother locations, even when tumour size is taken into consideration (14) .
CoNClUSIoN
Based on our study and review of the literature, the incidence of carcinoid tumours is about 1in100.000. Small bowel is the most frequent location for carcinoids. Carcinoidsinthe appendix present at an early age, they aref requently diagnosed incidentally,a nd they rarely metastasize and have an excellent prognosis. . ACKNoWlEDGEMENt thankst oD r. Helga Maartmann-Moe at the Gades Institute of pathology for providing data lists of patients with diagnosis of carcinoidtumours.
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